Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth H Mayer

Showing results (911-920 of 997) with videos related to

Pageof 100
Sort By:
Nature. Mental Health|August 18, 2025
Cognitive behavioral therapy for antiretroviral therapy adherence and treatment outcomes among people living with HIV: a systematic review and meta-analysisDavid R A Coelho, Belinda J Njiro, Mashavu H Yussuf, et al.
Preventing Chronic Disease|July 3, 2024
Preventive Service Usage and New Chronic Disease Diagnoses: Using PCORnet Data to Identify Emerging Trends, United States, 2018-2022Sandra L Jackson, Akaki Lekiachvili, Jason P Block, et al.
AIDS (London, England)|May 15, 2026
Impact of semaglutide on liver fibrosis score in people with HIV: findings from the CNICS cohortJimmy Ma, Stephanie A Ruderman, Lara Haidar, et al.
AIDS and Behavior|November 10, 2017
Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with MenAlex Carballo-Diéguez, Rebecca Giguere, Curtis Dolezal, et al.
AIDS and Behavior|December 5, 2024
Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States: Findings from the LITE StudyErin E Cooney, Meg Stevenson, Rodrigo A Aguayo-Romero, et al.
AIDS (London, England)|April 8, 2021
Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxisRogers Sekabira, Ian McGowan, Krista Yuhas, et al.
AIDS and Behavior|September 20, 2024
Technology-Based Interventions, with a Stepped Care Approach, for Reducing Sexual Risk Behaviors and Increasing PrEP Initiation Among Transgender and Gender Expansive Youth and Young AdultsCathy J Reback, Demetria Cain, Joshua A Rusow, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 11, 2015
Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061Iris Chen, Matthew B Connor, William Clarke, et al.
Clinical and Vaccine Immunology : CVI|April 22, 2016
Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year GapGlenda E Gray, Kenneth H Mayer, Marnie L Elizaga, et al.
Journal of Clinical Microbiology|October 25, 2013
HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithmMatthew M Cousins, Jacob Konikoff, Oliver Laeyendecker, et al.
Pageof 100

Showing results (911-920 of 997) with videos related to

Sort By:
Pageof 100
Nature. Mental Health|August 18, 2025
Cognitive behavioral therapy for antiretroviral therapy adherence and treatment outcomes among people living with HIV: a systematic review and meta-analysisDavid R A Coelho, Belinda J Njiro, Mashavu H Yussuf, et al.
Preventing Chronic Disease|July 3, 2024
Preventive Service Usage and New Chronic Disease Diagnoses: Using PCORnet Data to Identify Emerging Trends, United States, 2018-2022Sandra L Jackson, Akaki Lekiachvili, Jason P Block, et al.
AIDS (London, England)|May 15, 2026
Impact of semaglutide on liver fibrosis score in people with HIV: findings from the CNICS cohortJimmy Ma, Stephanie A Ruderman, Lara Haidar, et al.
AIDS and Behavior|November 10, 2017
Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with MenAlex Carballo-Diéguez, Rebecca Giguere, Curtis Dolezal, et al.
AIDS and Behavior|December 5, 2024
Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States: Findings from the LITE StudyErin E Cooney, Meg Stevenson, Rodrigo A Aguayo-Romero, et al.
AIDS (London, England)|April 8, 2021
Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxisRogers Sekabira, Ian McGowan, Krista Yuhas, et al.
AIDS and Behavior|September 20, 2024
Technology-Based Interventions, with a Stepped Care Approach, for Reducing Sexual Risk Behaviors and Increasing PrEP Initiation Among Transgender and Gender Expansive Youth and Young AdultsCathy J Reback, Demetria Cain, Joshua A Rusow, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 11, 2015
Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men: HIV Prevention Trials Network 061Iris Chen, Matthew B Connor, William Clarke, et al.
Clinical and Vaccine Immunology : CVI|April 22, 2016
Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year GapGlenda E Gray, Kenneth H Mayer, Marnie L Elizaga, et al.
Journal of Clinical Microbiology|October 25, 2013
HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithmMatthew M Cousins, Jacob Konikoff, Oliver Laeyendecker, et al.
Pageof 100